{"url":"https://lda.senate.gov/api/v1/filings/bec60408-e28e-4eab-881b-23f3b0f64ce1/","filing_uuid":"bec60408-e28e-4eab-881b-23f3b0f64ce1","filing_type":"RA","filing_type_display":"Registration - Amendment","filing_year":2015,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/bec60408-e28e-4eab-881b-23f3b0f64ce1/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"TJ Hartten","dt_posted":"2015-04-13T15:32:18-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"701 8th Street, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":41454,"url":"https://lda.senate.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":151558,"url":"https://lda.senate.gov/api/v1/clients/151558/","client_id":1006676,"name":"FAGRON NORTH AMERICA","general_description":"Pharmaceuticals","client_government_entity":false,"client_self_select":null,"state":"FL","state_display":"Florida","country":"US","country_display":"United States of America","ppb_state":"FL","ppb_state_display":"Florida","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-03-02"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to Drug Quality and Security Act (DQSA) and pharmacy compounding.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":37173,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":"Senate Committees on Aging and Gov Affairs","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[{"name":"FAGRON BV","contribution":"0.00","ownership_percentage":"100.00","address":"Kralingseweg 207-211","city":"Rotterdam 3062 CE","state":null,"state_display":null,"country":"NL","country_display":"Netherlands","ppb_city":null,"ppb_state":null,"ppb_state_display":null,"ppb_country":"NL","ppb_country_display":"Netherlands"}],"affiliated_organizations":[]}